Bayforest Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-865
Closed -$21.9K 750
2024
Q4
$21.9K Buy
+865
New +$21.9K 0.03% 564